NCT/Study#

NCT04762069 /

CNS-201

A Multicenter, Open-Label Study with a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients with Recurrent Glioblastoma Multiforme (WHO Grade IV) After Failure of Standard First Line Therapy

A Multicenter, Open-Label Study with a
Randomized Control Arm of the Efficacy, Safety,
and Pharmacokinetics of Intravenously Infused
Berubicin in Adult Patients with Recurrent
Glioblastoma Multiforme (WHO Grade IV) After
Failure of Standard First Line Therapy

DISEASE GROUP:
Neuro-Oncology
current phase:
Phase II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: